Both falcarindiol and tetrahydrocoptisine demonstrated direct interaction with pro-inflammatory cytokines IL6, IL1B, and TNF, key drivers of osteoclastogenesis and bone resorption in postmenopausal osteoporosis by activating inflammatory pathways linked to bone loss [36]. The gene discussed is IL1B; the disease is postmenopausal osteoporosis.